Amplification and rearrangement of c-erb B proto-oncogenes in cancer of human female genital tract
- PMID: 2569708
Amplification and rearrangement of c-erb B proto-oncogenes in cancer of human female genital tract
Abstract
There are two genes related to the v-erb B oncogene in the human genome. The c-erb B-1 gene encodes the epidermal growth factor receptor (EGF-r), and the c-erb B-2/neu gene encodes a receptor-like protein very similar to, but distinct from the EGF-r. Southern blot analysis of DNAs from 15 fresh human ovarian carcinomas showed that the c-erb B-2/neu gene was amplified in 3 tumors. The c-erb B-1/EGF-r gene was not amplified. However, in one case of adenocarcinoma of uterine endometrium, the c-erb B-1/EGF-r was found to be rearranged in the 5' region of this gene. The genomic structure of the rearranged c-erb B-1/EGF-r gene is similar to those found in the chicken v-erb B oncogene, which produces a truncated form of the EGF-r. The results suggest that amplification of the c-erb B-2/neu gene may play a role in the pathogenesis of ovarian carcinoma. Further, the human c-erb B-1/EGF-r gene in adenocarcinoma of uterine endometrium may be activated by a similar mechanism as that in the chicken v-erb B oncogene.
Similar articles
-
Oncogene abnormalities in astrocytomas: EGF-R gene alone appears to be more frequently amplified and rearranged compared with other protooncogenes.Mod Pathol. 1991 Mar;4(2):183-6. Mod Pathol. 1991. PMID: 1675468
-
C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.Anticancer Res. 1990 Jan-Feb;10(1):189-92. Anticancer Res. 1990. PMID: 2185686
-
Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor.Nature. 1986 Jan 16-22;319(6050):230-4. doi: 10.1038/319230a0. Nature. 1986. PMID: 3003577
-
The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).Anticancer Res. 1989 Sep-Oct;9(5):1265-79. Anticancer Res. 1989. PMID: 2686529 Review.
-
Amplification of cellular oncogenes: a predictor of clinical outcome in human cancer.Genes Chromosomes Cancer. 1990 Jan;1(3):181-93. doi: 10.1002/gcc.2870010302. Genes Chromosomes Cancer. 1990. PMID: 1982063 Review.
Cited by
-
Prognostic value of c-erbB-2 expression in uterine cervical carcinoma.J Clin Pathol. 1992 Jul;45(7):594-6. doi: 10.1136/jcp.45.7.594. J Clin Pathol. 1992. PMID: 1355495 Free PMC article.
-
Transcriptional repression of the neu protooncogene by the adenovirus 5 E1A gene products.Proc Natl Acad Sci U S A. 1990 Jun;87(12):4499-503. doi: 10.1073/pnas.87.12.4499. Proc Natl Acad Sci U S A. 1990. PMID: 1972274 Free PMC article.
-
The TRAIL to targeted therapy of breast cancer.Adv Cancer Res. 2009;103:43-73. doi: 10.1016/S0065-230X(09)03003-6. Adv Cancer Res. 2009. PMID: 19854352 Free PMC article. Review.
-
Adenovirus type 5 E1A gene products act as transformation suppressors of the neu oncogene.Mol Cell Biol. 1991 Mar;11(3):1745-50. doi: 10.1128/mcb.11.3.1745-1750.1991. Mol Cell Biol. 1991. PMID: 1671710 Free PMC article.
-
Critical determination of the frequency of c-erbB-2 amplification in breast cancer.Br J Cancer. 1994 Sep;70(3):434-9. doi: 10.1038/bjc.1994.323. Br J Cancer. 1994. PMID: 7915911 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous